Skip to main content
Reimbursement & Payment Models

What Is 340B Drug Pricing Program?

Quick answer

A federal program that requires drug manufacturers to sell outpatient drugs at discounted prices to eligible safety-net providers, known as covered entities.

Written & reviewed by the Unlimited Systems Revenue Cycle TeamLast reviewed May 2026

Key takeaways

  • 340B Drug Pricing Program is a reimbursement & payment models concept in healthcare revenue cycle management.
  • A federal program that requires drug manufacturers to sell outpatient drugs at discounted prices to eligible safety-net providers, known as covered entities.
  • Spans fee-for-service through value-based and risk contracts

340B Drug Pricing Program explained

Covered entities include certain hospitals, community health centers, and other eligible clinics. The savings are intended to stretch resources to serve more patients.

340B claims carry specific modifier and reporting requirements for Medicare and many state Medicaid programs, and duplicate-discount rules must be followed.

Where 340B Drug Pricing Program fits in the revenue cycle

340B Drug Pricing Program sits within the contractual layer that determines how much a practice is paid. It relates to how providers are paid, the payment methodologies and value-based arrangements that set reimbursement.

You'll encounter 340B Drug Pricing Program on payer communications, billing reports, and in conversations between front-office, coding, and accounts-receivable teams.

Why 340B Drug Pricing Program matters for your practice

How a service is paid is as important as whether it's coded correctly. Fee-for-service, capitation, bundled payments, and value-based contracts each carry different billing, documentation, and reporting requirements. Understanding these models is essential for forecasting revenue and succeeding under changing payer arrangements.

  • Determines the methodology behind each payment
  • Spans fee-for-service through value-based and risk contracts
  • Each model carries distinct billing and reporting rules
  • Increasingly tied to quality and outcomes, not just volume

340B Drug Pricing Program in practice

Knowing what 340B Drug Pricing Program means is only useful if it changes what your team does. In a modern revenue cycle, that means catching issues related to reimbursement & Payment Models earlier, documenting and coding them correctly, and using technology to flag exceptions automatically rather than discovering them after a claim is denied.

This is exactly where a specialty-built revenue cycle platform earns its keep: by encoding the rules behind terms like 340B Drug Pricing Program directly into the workflow, so clean claims go out the first time and your team works by exception instead of chasing problems after the fact.

340B Drug Pricing Program: frequently asked questions

What is 340B Drug Pricing Program?

A federal program that requires drug manufacturers to sell outpatient drugs at discounted prices to eligible safety-net providers, known as covered entities.

What does 340B Drug Pricing Program mean in medical billing?

In medical billing, 340B Drug Pricing Program falls under Reimbursement & Payment Models. It relates to how providers are paid, the payment methodologies and value-based arrangements that set reimbursement.

Why is 340B Drug Pricing Program important in the revenue cycle?

How a service is paid is as important as whether it's coded correctly. Fee-for-service, capitation, bundled payments, and value-based contracts each carry different billing, documentation, and reporting requirements. Understanding these models is essential for forecasting revenue and succeeding under changing payer arrangements.

Authoritative sources

For the most current rules and requirements, consult the primary sources that govern this area of healthcare billing:

Unlimited Systems Revenue Cycle Team
RCM & medical billing specialists

Unlimited Systems has built specialty revenue cycle technology for healthcare providers for two decades. This glossary is maintained by our in-house team of billing, coding, and reimbursement specialists.

Put 340B Drug Pricing Program to work in your practice

See how the Unlimited Systems platform automates clean claims, denial management, eligibility verification, and more across your revenue cycle.

We Love Hearing From Our Users

Using our product doesn't just mean quality software, but also access to a community to keep you connected to your peers and to your product team.

★★★★★4.8/5G2
★★★★★5/5Gartner
“

The system continues to grow with features as it should, with how healthcare changes. So, if you are looking for a company that is innovative and truly cares, I would recommend Unlimited Financials.

Ernelita Dacumos
Billing Manager, SHOM
“

Unlimited Financials has been the easiest and best practice management system I have used. It is easy to navigate and do what I need to do.

Melissa Shook
Medical Biller, SHOM
“

We have been on Unlimited Financials for over three years and love it. Our claims are being processed faster and more efficiently, which means we are receiving payment more quickly.

Renee Bernacchi
Accounts Receivable Coordinator, COAS
“

Unlimited Financials has allowed us to extend our workforce in some areas due to the workflow efficiencies and given a better patient experience.

Mel Davies
CFO, Oregon Oncology Specialists
“

Knowledge of the patient's coverage has been a game changer. The ability to verify benefits before the patient comes in has saved us on time and denials, so there is no delay in treatment.

Alisha Haslem
Patient Advocate Manager, Utah Cancer Specialists
“

Using Unlimited Systems has allowed us to get a much better handle on our AR and claim management.

Erin Wilcher
Executive Director, Commonwealth Cancer Center